Simplex Trading
HRMY icon

Simplex Trading’s Harmony Biosciences HRMY Stock Holding History

Simplex Trading’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,003
Closed -$165K – 9189
2025
Q3 		$165K Buy
+6,003
New +$207K ﹤0.01% 5167
2024
Q3 		– Sell
-5,569
Closed -$196K – 8936
2024
Q2 		$168K Buy
+5,569
New +$167K ﹤0.01% 4820
2023
Q4 		– Sell
-1,914
Closed -$53.4K – 9235
2023
Q3 		$62K Buy
1,914
+1,736
+975% +$60.3K ﹤0.01% 5597
2023
Q2 		$6K Buy
+178
New +$6.14K ﹤0.01% 7791
2022
Q4 		– Sell
-730
Closed -$40.1K – 9685
2022
Q3 		$32K Buy
730
+18
+3% +$878 ﹤0.01% 6991
2022
Q2 		$34K Buy
712
+612
+612% +$27.6K ﹤0.01% 6980
2022
Q1 		$4K Buy
+100
New +$4.08K ﹤0.01% 9562

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Simplex Trading's HRMY Position: Q4 2025 in Review

Simplex Trading sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 6,003 shares — an estimated $165K sold.

Simplex Trading first reported a position in HRMY in Q1 2022 and held it in 7 quarters. The position peaked at $168K in Q2 2024. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Simplex Trading reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 6,003 Harmony Biosciences shares in Q4 2025, an estimated $165K.
  • Simplex Trading first reported a position in Harmony Biosciences in Q1 2022 and held it in 7 quarters.
  • Simplex Trading's Harmony Biosciences position peaked at $168K in Q2 2024.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.